U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954428) titled 'Clinical Trial of Intranasal Delivery of NT-301' on March 07. Brief Summary: The purpose of ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953154) titled 'Monocyte Distribution Width (MDW): An Early Marker of Sepsis in Patients With Comorbidities' ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952933) titled 'Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenita... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952660) titled 'A Study to Learn More About TIVDAK in Women With Cervical Cancer That Has Come Back' on April... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953960) titled 'A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952673) titled 'Study on Multi-Modality Models of Cardiac Function in Healthy Individuals' on April 19. Brie... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954220) titled 'Baduanjin Exercises on Shoulder Dysfunction Post Thyroidectomy' on April 24. Brief Summary: ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953765) titled 'A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953557) titled 'Evaluation of the Salivary-free Amino Acids Levels (Glycine , Proline , Lysine , and Alanine ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953726) titled 'Comparing the Safety and Efficacy of Apixaban and Rivaroxaban' on April 23. Brief Summary: *... Read More